Sprint Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Sep '24 Sep 11, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2014
Market Capitalization	87	121	22	191	163	151	Upgrade
Market Cap Growth	159.67%	449.78%	-88.47%	17.26%	8.20%	-27.98%	Upgrade
Enterprise Value	51	66	-5	105	128	139	Upgrade
Last Close Price	1.24	1.74	0.55	4.79	7.31	11.62	Upgrade
PE Ratio	5.88	-276.54	-0.39	-5.51	-2.87	-6.05	Upgrade
PS Ratio	1.00	2.34	265.47	5.45	8.49	4.45	Upgrade
PB Ratio	4.63	4.36	0.78	2.71	17.82	13.67	Upgrade
P/FCF Ratio	4.18	5.93	-0.37	-4.46	-5.06	-5.36	Upgrade
P/OCF Ratio	4.27	5.30	-0.37	-4.76	-5.06	-5.38	Upgrade
EV/Sales Ratio	0.59	1.28	-56.57	3.01	6.64	4.12	Upgrade
EV/EBITDA Ratio	3.36	-75.42	0.08	-4.23	-3.45	-7.08	Upgrade
EV/EBIT Ratio	3.54	-49.94	0.08	-4.14	-3.38	-6.82	Upgrade
EV/FCF Ratio	2.44	3.24	0.08	-2.46	-3.96	-4.96	Upgrade
Debt / Equity Ratio	-	-	-	-	1.09	-	Upgrade
Debt / FCF Ratio	-	-	-	-	-0.31	-	Upgrade
Asset Turnover	2.42	1.04	0.00	0.62	0.73	1.70	Upgrade
Quick Ratio	1.47	1.67	3.78	8.75	1.30	1.85	Upgrade
Current Ratio	1.47	1.67	3.78	8.75	1.33	2.11	Upgrade
Return on Equity (ROE)	128.60%	-1.57%	-122.00%	-63.02%	-424.50%	-453.92%	Upgrade
Return on Assets (ROA)	25.05%	-1.66%	-65.01%	-28.29%	-89.46%	-64.23%	Upgrade
Return on Capital (ROIC)	78.04%	-2.96%	-76.81%	-35.53%	-156.14%	-118.85%	Upgrade
Earnings Yield	17.00%	-0.36%	-273.08%	-13.13%	-26.26%	-14.30%	Upgrade
FCF Yield	23.94%	16.85%	-268.02%	-22.41%	-19.78%	-18.66%	Upgrade
Buyback Yield / Dilution	-22.41%	-65.98%	-45.85%	-71.85%	-49.55%	-26.97%	Upgrade
Total Shareholder Return	-22.41%	-65.98%	-45.85%	-71.85%	-49.55%	-26.97%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.